Ramipril (Rampril (10 mg)) is an angiotensin-converting enzyme (ACE) inhibitor, used alone or in combination with other medications to treat high blood pressure. It is also used to reduce the risk of ...
Ramipril has been used in twice daily dose of 5 mg in most heart failure trials, whereas the dose used in Heart Outcomes Prevention Evaluation (HOPE) study was 10 mg once at bedtime. The HOPE ...
A combination of ramipril (Altace) 10 mg daily plus telmisartan (Micardis) 80 mg daily does not reduce mortality or cardiovascular morbidity compared with ramipril alone, based on a randomized trial ...
The failure of patients to take their blood-pressure (BP)-lowering medications according to prescription (non-adherence) and the discontinuation of treatment altogether (non-persistence) by patients ...
March 31, 2008 (Chicago, IL) - The angiotensin receptor blocker (ARB) telmisartan (Micardis, Boehringer Ingelheim) was "noninferior" to the ACE inhibitor ramipril in patients with vascular disease or ...
The evidence for the efficacy of ramipril in relieving the symptoms of peripheral arterial disease is very limited. Two small RCTs (Ahimastos et al. 2006, n=40 and Shahin et al. 2013a, n=33) found ...
BEIJING, October 23 /PRNewswire/ -- New results from the landmark ONTARGET(R) Trial show that, in Asian patients at high risk of cardiovascular disease (CVD), telmisartan (MICARDIS(R)) 80mg is as ...
Ramipril (Proace (10 mg)) is an angiotensin-converting enzyme (ACE) inhibitor, used alone or in combination with other medications to treat high blood pressure. It is also used to reduce the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results